key: cord-0982470-rmqd6o5e
authors: Ayten, Omer; Iscanli, Insa Gul Ekiz; Canoglu, Kadir; Ozdemir, Cengiz; Saylan, Bengü; Caliskan, Tayfun; Akin, Hasan; Tezel, Cağatay
title: Tracheal stenosis after prolonged intubation due to Covid 19
date: 2022-02-11
journal: J Cardiothorac Vasc Anesth
DOI: 10.1053/j.jvca.2022.02.009
sha: f855885fe48478649fda662e55868d7568d95783
doc_id: 982470
cord_uid: rmqd6o5e

Objectives We aimed to evaluate the characteristics and management outcomes of patients who developed tracheal stenosis after invasive mechanical ventilation (IMV) due to COVID-19 in this study. Design, settings and participants The data of 7 patients with tracheal stenosis and 201 patients without tracheal stenosis after IMV due to COVID-19 between March 2020 and October 2021 were retrospectively analyzed. Interventions Flexible bronchoscopy was performed for the diagnosis of tracheal stenosis and the evaluation of the treatment's effectiveness and rigid bronchoscopy was applied for the dilatation of tracheal stenosis. Measurements and Main Results In the follow-up period, tracheal stenosis was observed in 7 of 208 patients (2 women, 5 men, 3.3%). The patients were divided into two groups as patients with tracheal stenosis (n=7) and patients without tracheal stenosis (n=201). There was no statistically significant difference between the two groups in terms of age, gender, body mass index (BMI) and comorbidities (p > 0.05). The mean duration of IMV of the patients with tracheal stenosis was longer than patients without tracheal stenosis (27.9 ± 13 vs 11.2 ± 9 days, p < 0.0001, respectively). Three (43%) of the stenoses were web-like and four (57%) of them were complex type stenosis. The mean length of the stenoses was 1.81 ± 0.82 cm. Three of the patients were successfully treated with bronchoscopic dilatation and four of them were treated with tracheal resection. Conclusions Tracheal stenosis developed in 7 (3.3%) of 208 patients with COVID-19 who were treated with IMV. The most important characteristics of patients with tracheal stenosis was prolonged IMV support.

Tracheal stenosis is a potentially life-threatening condition that generally develops iatrogenically as a result of endotracheal intubation or tracheostomy. It has long been known that ischemia, secondary to prolonged intubation, is the primary source of scarring injury in tracheal stenoses 1 is to postpone the tracheostomy until it is determined that the patient is cleared from the virus and the patient does not need to be ventilated in the prone position. This practice means that patients remain intubated for up to 3-4 weeks and have an increased risk of tracheal stenosis 3 .

Our hospital is one of the first pandemic clinics in our country and is one of the centers with the highest number of COVID-19 patients. During the pandemic, our hospital served five ICUs with a total bed capacity of 40. In this study, we aimed to evaluate the characteristics and management outcomes of patients who developed tracheal stenosis after IMV due to respiratory failure due to COVID-19. We compared the clinical characteristics of patients with and those without tracheal stenosis after IMV.

The data of 7 patients who developed tracheal stenosis and 201 patients who did not develop tracheal stenosis after IMV due to critical COVID-19 in our hospital's ICUs between March 2020 and October 2021 were retrospectively analyzed. All patients with COVID-19 were diagnosed using next-generation sequencing or real-time reverse transcription polymerase chain reaction (PCR). The demographic features of the patients, comorbidities, duration of mechanical ventilator support, time from endotracheal intubation to tracheostomy, duration of tracheostomy, time from extubation to diagnosis, the type, size, and localization of the stenosis, categories of the endoscopic interventions and surgeries applied, and their success rates were analyzed using the patients' medical records. The same extubation criteria were used for other non-COVID-19 patients. Ethical approval for the study was obtained from the Umraniye Training and Research Hospital Ethics Committee (October 18, 2021/326).

The diagnosis of tracheal stenosis was confirmed with flexible bronchoscopy (FB) (Olympus BF1T150, Tokyo, Japan) when clinical and radiological signs led to the suspicion of tracheal stenosis. The type of stenosis was classified as web-like or complex. The size and length of the stenosis were measured using chest tomography and during FB evaluation. The localization of stenosis was classified as subglottic, 1/3 of the upper part of the trachea, middle part of the trachea, and 1/3 lower part of the trachea. The size of stenosis was classified according to the degree of stenosis of the tracheal lumen in four grades: grade I (≤50%), grade II (51-70%), grade III (>70%), and grade IV (complete obstruction). FB was performed to evaluate the effectiveness of the treatment and during follow-ups, and rigid bronchoscopy (Novotech rigid bronchoscope, Dutau Novotech, Marseille, France) was applied for the dilatation of stenosis.

Patients with tracheal stenosis who could not be treated with rigid bronchoscopy were treated with surgery.

All patients were followed up after discharge using the hospital electronic medical records system and the national medical database called "E pulse," which includes all the medical records of the patients (epicrisis, anamnesis, physical examination, laboratory parameters, and radiological images). Symptoms related to tracheal stenosis or tracheal stenosis diagnosed radiologically or clinically in a different health institution were not observed in the national medical database called "E pulse" of 201 patients who did not develop tracheal stenosis.

Parametric tests were used without normality tests because of the suitability of the central limit theorem. While performing statistical data of continuous structure, average and standard deviation, and minimum and maximum values were used. When defining categorical variables, frequency and percentage values were used. Chi-square test statistics were used to evaluate the relationships between categorical variables. Student's t-test was used to compare the means of the two groups. The statistical significance level of the data was considered at p < 0.05. The MedCalc statistics package program and www.e-picos.com New York, New York software were used to evaluate the data 4 .

During the study period, 586 patients were followed up with IMV due to respiratory failure due to COVID-19 in the ICU of our hospital. Of these patients, 350 died in the ICU (59.7%). Approximately 28 patients died during the follow-up period after discharge from the ICU. During the follow-up period, tracheal stenosis was observed in 7 of 208 patients (2 female, 5 male, 3.3%) who were successfully discharged from the hospital after being extubated. The mean age of the patients was 61.7 ± 13 years.

The patients were divided into two groups: patients with tracheal stenosis (n=7) and patients without tracheal stenosis (n=201). The demographics and clinical characteristics of the patients are summarized in Table 1 . There was no statistically significant difference between the two groups in terms of age, sex, body mass index (BMI), and comorbidities (p > 0.05) ( Table 1) . Twenty patients (9.6%) underwent tracheostomy during the weaning phase and were discharged from the ICU after their tracheostomy was closed. All patients who underwent tracheostomy had negative PCR results before tracheostomy. The frequency of tracheostomy in patients with tracheal stenosis (57.1%, n = 4) was higher than that in patients without tracheal stenosis (8%, n = 16) (p < 0.0001). The mean follow-up duration of patients after discharge from the ICU was 358.2 ± 158 days. There was no statistical difference between the two groups in terms of tracheostomy duration (days) and time from endotracheal intubation to tracheostomy (day) (p = 0.54 and p = 0.67, respectively) ( Table 1 ). The mean duration of IMV was 38.3 ± 14 days. The mean duration of IMV was longer in patients with tracheal stenosis than in those without tracheal stenosis (27.9 ± 13 vs 11.2 ± 9, p < 0.0001, respectively). ICU length of stay (39.9 ± 16 days vs 17.1 ± 10 days, p < 0.01) and total (ICU plus clinic) length of stay (48.7 ± 19 days vs. 25.1 ± 14 days, p < 0.0001) were longer in patients with tracheal stenosis (Table 1) .

All patients with tracheal stenosis had complaints of dyspnea, wheezing, and stridor on physical examination. Five patients (71%) were admitted to the emergency department, and two patients (29%) were admitted to the outpatient clinic. The time from extubation to diagnosis of tracheal stenosis was 114.57 ± 85 days. Three (43%) of the stenoses were web-like and four (57%) were complex-type ( Figure   1 ). The majority of stenoses (n=6, 86%) were localized in the upper 1/3 of the trachea and were grade 3 (n=4, 58%). The mean length of the stenoses was 1.81 ± 0.82 cm. The characteristics of the patients with tracheal stenosis are summarized in Table 2 .

Bronchoscopic dilatation was performed once in patients with web-like stenosis. Restenosis was not observed in any of the patients with FB control one month after dilation. In patients with complex stenosis, at least one bronchoscopic dilatation was performed prior to surgery. Bronchoscopic dilatation was performed at two different times in patients 1 and 6, whose surgery was delayed due to COVID-19 and restenosis. Furthermore, bronchoscopic dilatation was performed five times on patient 5, who did not accept surgery at first but was later convinced for surgery. Tracheal resection was performed in four patients with complex-type stenosis (Table 3 ). There were no procedural complications in patients who underwent bronchoscopic dilation. No complications were encountered in four of the seven patients who underwent tracheal resection. The mean follow-up period of the patients was 239.7 ± 180 days.

During this period, none of the patients had any symptoms or signs related to restenosis or late complications secondary to surgery.

Although this study included seven patients with tracheal stenoses, to our knowledge, it is the largest series evaluating tracheal stenoses due to COVID-19. The primary disease causing mechanical ventilation, airway interventions in the ICU, and accompanying comorbidities are the most important risk factors in the development of post-intubation tracheal stenosis (PITS) and post-tracheostomy tracheal stenosis (PTTS). The stenosis group in which the course of COVID-19 was worse included patients with advanced age and accompanying comorbidities 5 . In this group, there was a 3-fold difference between the hospitalization times of the patients followed in the clinic and the ICU (5 (3-7) days vs. 15 (9-23) days, p<.001) 6 . Patients who develop respiratory failure due to COVID-19 are followed on a long-term (mean, 18 days) mechanical ventilator support with high positive end-expiratory pressures 2 . In our study, there was no statistically significant difference between patients with tracheal stenosis and those without tracheal stenosis in terms of age, sex, BMI, and comorbidities, and the mean duration of IMV was quite high (38.3 ± 14 days). The mean duration of IMV in patients with tracheal stenosis was longer than that in patients without tracheal stenosis (27.9 ± 13 vs 11.2 ± 9, p < 0.0001, respectively), and this prolonged IMV support was the main risk factor for the development of tracheal stenosis. Moreover, ICU length of stay (39.9 ± 16 days vs 17.1 ± 10 days, p < 0.01) and total (ICU plus clinic) length of stay (48.7 ± 19 days vs 25.1 ± 14 days, p < 0.0001) were longer in patients with tracheal stenosis.

In our study, despite long-term IMV follow-up with an endotracheal tube, tracheostomy was performed in only 9.6% (n=20) of the patients. This situation may be related to the high risk of virus transmission during tracheostomy, the prolongation of virus clearance, the continuation of the need for prone position ventilation, or the death of most patients within the first 14 days. We could not provide clear information on this subject due to the inadequacy of medical records, including the virus clearance time and the frequency and duration of prone position ventilation of the patients. Whilst the overall mechanical ventilation time was much higher in the tracheal stenosis group, the time to tracheostomy and the tracheostomy duration was no different between the groups. The lack of difference between the groups in the time to tracheostomy may be related to the waiting for PCR negativity before the tracheostomy procedure in patients planned for tracheostomy. Also this may be related to other factors not measured that might have contributed to the tracheal stenosis, such as much greater vasopressor use, or longer periods of hypoxia in the tracheal stenosis group that contributed to tissue ischemia.

Although the frequency of PITS in intubated patients is reported to be-1-21%, symptomatic cases with severe stenosis constitute 1-2% of patients 7 . Symptoms and signs of tracheal stenosis may appear immediately after extubation or within a few years 8 . The work of breathing in the central airway obstruction and tracheal stenosis depends on the pressure change and is mainly affected by the degree of obstruction and airflow rate. Mild tracheal narrowing (i.e., ≤ 50% reduction in cross-sectional area [CSA] ) is unlikely to cause symptoms as the pressure is similar to that at the normal glottic opening.

Moderate obstruction (51-70% reduction in CSA) produces variable symptoms, with significant pressure drops occurring, especially in situations requiring high flow such as exertion. Sedentary patients may have been asymptomatic during this stage. Severe stenosis (> 71% reduction in CSA) causes a significant pressure drop, and most of these patients are symptomatic even at rest 9, 10 . The actual incidence of PITS and PETS in asymptomatic patients is unknown. In our study, 208 of 586 patients who were intubated during the COVID-19 pandemic were successfully discharged, and 7 of these 208 patients (3.3%) were diagnosed with tracheal stenosis. Although two patients had mild tracheal narrowing (≤ 50% reduction in CSA), they were symptomatic. This may be related to the severity of COVID-19 and delayed functional recovery. Since pulmonary function tests cannot be performed for a long time under pandemic conditions, the duration and degree of functional recovery of the patients is unknown. The duration of the patients from extubation to diagnosis was quite long (114.57 ± 85 days). This long diagnosis period was thought to be due to many factors such as the late development of stenosis, the unwillingness of patients to come to the hospital after long-term intensive care follow-up, the disruptions experienced in the outpatient clinic examinations and health system due to COVID-19, and the inability of patients to distinguish stenosis-related symptoms from COVID-19 related symptoms.

Endoscopic procedures are accepted as the first treatment option in the treatment of web-like stenosis smaller than 1 cm and not accompanied by tracheal malacia 11 . Approximately 60% success is achieved in these patients after 1 ± 3 interventions with endoscopic procedures and the mucosa-sparing technique 12 .

In complex-type stenoses, endoscopic procedures are contraindicated because the risk of recurrence is high and the stenosis length can increase, which can reduce the chance of surgery. Nevertheless, these endoscopic procedures can be applied prior to surgery 13, 14 . In complex-type stenosis, tracheal resections can be performed up to 4-6 cm, but in longer stenoses, surgery is not recommended due to the high frequency of anastomotic complications 15 . In our study, the mean stenosis length was 1.81 ± 0.82 cm, and the majority of stenoses (n=6, 86%) were observed in the 1/3 proximal part of the trachea. Dilatation was performed once in three patients with web-like stenosis. Restenosis was not observed in the control flexible bronchoscopy at the 1st month follow-up after dilation. In patients with complex stenosis, dilatation was performed to save time for surgery. No surgical complications or postoperative restenosis were observed in four patients who underwent tracheal resection.

The most important limitation of our study was the retrospective analysis of the cases. Therefore, only patients with symptoms suggestive of tracheal stenosis in the post-intensive care follow-up were recruited for the study. However, symptoms related to tracheal stenosis or tracheal stenosis diagnosed radiologically or clinically in a different health institution were not observed in the national medical database called "E pulse" of 201 patients who did not develop tracheal stenosis..

In this single-center retrospective study, tracheal stenosis developed in 7 (3.3%) of 208 patients who were successfully discharged from the hospital after being extubated. The most important characteristic of patients who developed tracheal stenosis was prolonged IMV support. Three of the patients were successfully treated with bronchoscopic dilatation and four underwent tracheal resection.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 

A multi-institutional analysis of tracheotomy complications

COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS

Admitted to ICUs of the Lombardy Region

Long-term intubation and high rate of tracheostomy in COVID-19 patients might determine an unprecedented increase of airway stenoses: a call to action from the European Laryngological Society

Likert scales, levels of measurement and the "laws" of statistics

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit

Surgical considerations in tracheal stenosis

Benign stenosis of the trachea

Tracheal stenosis: a flow dynamics study

Central Airway Obstruction: Benign Strictures, Tracheobronchomalacia, and Malignancy-related Obstruction

The role of interventional bronchoscopy in the management of post-intubation tracheal stenosis: A 20-year experience

Concentric tracheal and subglottic stenosis. Management using the Nd-YAG laser for mucosal sparing followed by gentle dilatation

State of the art in tracheal surgery: a brief literature review

Long-term results of laryngotracheal resection for benign stenosis from a series of 109 consecutive patients

Complications after tracheal resection and reconstruction: prevention and treatment

Yes